{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:07:44Z","timestamp":1746850064653,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"DOI":"10.7759\/cureus.83778","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:28:56Z","timestamp":1746790136000},"source":"Crossref","is-referenced-by-count":0,"title":["Bone Mineral Density Assessment by Dual-Energy X-Ray Absorptiometry (DEXA) Versus Serum Tartrate-Resistant Acid Phosphatase 5b (TRAP-5b) in Children With Classic Salt-Losing Congenital Adrenal Hyperplasia"],"prefix":"10.7759","author":[{"given":"Noura M","family":"ElBakry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Khalf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mahgoob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser PW","year":"2003","unstructured":"Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003, 349:776-88. 10.1056\/NEJMra021561","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-4-200202190-00012","article-title":"Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"136","author":"Merke DP","year":"2002","unstructured":"Merke DP, Bornstein SR, Avila NA, Chrousos GP. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med. 2002, 136:320-34. 10.7326\/0003-4819-136-4-200202190-00012","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.8620871.x","article-title":"Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency","volume":"45","author":"J\u00e4\u00e4skel\u00e4inen J","year":"1996","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Voutilainen R. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin Endocrinol (Oxf). 1996, 45:707-13. 10.1046\/j.1365-2265.1996.8620871.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1430667","article-title":"Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy","volume":"143","author":"Hagenfeldt K","year":"2000","unstructured":"Hagenfeldt K, Martin Ritz\u00e9n E, Ringertz H, et al.. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol. 2000, 143:667-71. 10.1530\/eje.0.1430667","journal-title":"Eur J Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.12.4320","article-title":"The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia","volume":"82","author":"Girgis R","year":"1997","unstructured":"Girgis R, Winter JS. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1997, 82:3926-9. 10.1210\/jcem.82.12.4320","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2007.06.019","article-title":"Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"68","author":"Bachelot A","year":"2007","unstructured":"Bachelot A, Chakhtoura Z, Rouxel A, et al.. Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Endocrinol (Paris). 2007, 68:274-80. 10.1016\/j.ando.2007.06.019","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(99)70020-x","article-title":"Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia","volume":"135","author":"Leonard MB","year":"1999","unstructured":"Leonard MB, Propert KJ, Zemel BS, et al.. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr. 1999, 135:182-8. 10.1016\/s0022-3476(99)70020-x","journal-title":"J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/10408369109106867","article-title":"Osteocalcin: diagnostic methods and clinical applications","volume":"28","author":"Power MJ","year":"1991","unstructured":"Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci. 1991, 28:287-335. 10.3109\/10408369109106867","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00493","article-title":"Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"11","author":"Rangaswamaiah S","year":"2020","unstructured":"Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, Falhammar H. Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020, 11:493. 10.3389\/fendo.2020.00493","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-003-0434-6","article-title":"Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density","volume":"21","author":"de Almeida Freire PO","year":"2003","unstructured":"de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, et al.. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. J Bone Miner Metab. 2003, 21:396-401. 10.1007\/s00774-003-0434-6","journal-title":"J Bone Miner Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(96)00003-8","article-title":"Bone density in young patients with congenital adrenal hyperplasia","volume":"18","author":"Mora S","year":"1996","unstructured":"Mora S, Saggion F, Russo G, et al.. Bone density in young patients with congenital adrenal hyperplasia. Bone. 1996, 18:337-40. 10.1016\/8756-3282(96)00003-8","journal-title":"Bone"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2001.21678","article-title":"Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density","volume":"50","author":"Arisaka O","year":"2001","unstructured":"Arisaka O, Hoshi M, Kanazawa S, et al.. Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density. Metabolism. 2001, 50:377-9. 10.1053\/meta.2001.21678","journal-title":"Metabolism"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10339","article-title":"Effect of glucocorticoids on bone density","volume":"41","author":"Rehman Q","year":"2003","unstructured":"Rehman Q, Lane NE. Effect of glucocorticoids on bone density. Med Pediatr Oncol. 2003, 41:212-6. 10.1002\/mpo.10339","journal-title":"Med Pediatr Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2007.20.2.227","article-title":"Bone mineral status in children with congenital adrenal hyperplasia","volume":"20","author":"Fleischman A","year":"2007","unstructured":"Fleischman A, Ringelheim J, Feldman HA, Gordon CM. Bone mineral status in children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2007, 20:227-35. 10.1515\/jpem.2007.20.2.227","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.00851.x","article-title":"Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia","volume":"45","author":"Guo CY","year":"1996","unstructured":"Guo CY, Weetman AP, Eastell R. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 1996, 45:535-41. 10.1046\/j.1365-2265.1996.00851.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000053253","article-title":"Height, bone mineral density and bone markers in congenital adrenal hyperplasia","volume":"54","author":"Paganini C","year":"2000","unstructured":"Paganini C, Radetti G, Livieri C, et al.. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res. 2000, 54:164-8. 10.1159\/000053253","journal-title":"Horm Res"},{"key":"ref17","article-title":"The Epidemiology and Pathogenesis of Osteoporosis","author":"Rosen CJ","year":"2000","unstructured":"Rosen CJ. The Epidemiology and Pathogenesis of Osteoporosis.  Feingold KR, Anawalt B, Blackman MR, et al. (ed): Endotext [Internet], South Dartmouth (MA); 2000."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.4.671","article-title":"Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia","volume":"100","author":"Gussiny\u00e9 M","year":"1997","unstructured":"Gussiny\u00e9 M, Carrascosa A, Potau N, et al.. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics. 1997, 100:671-4. 10.1542\/peds.100.4.671","journal-title":"Pediatrics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0865","article-title":"Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia","volume":"168","author":"Falhammar H","year":"2013","unstructured":"Falhammar H, Filipsson NH, Wedell A, et al.. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur J Endocrinol. 2013, 168:331-41. 10.1530\/EJE-12-0865","journal-title":"Eur J Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle WJ","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003, 423:337-42. 10.1038\/nature01658","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064753","article-title":"RANK-L and RANK: T cells, bone loss, and mammalian evolution","volume":"20","author":"Theill LE","year":"2002","unstructured":"Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002, 20:795-823. 10.1146\/annurev.immunol.20.100301.064753","journal-title":"Annu Rev Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong YY","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, et al.. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402:304-9. 10.1038\/46303","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0474","article-title":"T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction","volume":"104","author":"Colucci S","year":"2004","unstructured":"Colucci S, Brunetti G, Rizzi R, et al.. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction. Blood. 2004, 104:3722-30. 10.1182\/blood-2004-02-0474","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050281","article-title":"An update on the diagnosis and assessment of osteoporosis with densitometry","volume":"11","author":"Kanis JA","year":"2000","unstructured":"Kanis JA, Gl\u00fcer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int. 2000, 11:192-202. 10.1007\/s001980050281","journal-title":"Osteoporos Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1370209","article-title":"Glucocorticoid osteoporosis--mechanisms and management","volume":"137","author":"Reid IR","year":"1997","unstructured":"Reid IR. Glucocorticoid osteoporosis--mechanisms and management. Eur J Endocrinol. 1997, 137:209-17. 10.1530\/eje.0.1370209","journal-title":"Eur J Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650111008","article-title":"Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone","volume":"11","author":"Conaway HH","year":"1996","unstructured":"Conaway HH, Grigorie D, Lerner UH. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone. J Bone Miner Res. 1996, 11:1419-29. 10.1002\/jbmr.5650111008","journal-title":"J Bone Miner Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650040202","article-title":"Bone histomorphometry in glucocorticoid-induced osteoporosis","volume":"4","author":"Dempster DW","year":"1989","unstructured":"Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 1989, 4:137-41. 10.1002\/jbmr.5650040202","journal-title":"J Bone Miner Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein RS","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998, 102:274-82. 10.1172\/JCI2799","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/320765-bone-mineral-density-assessment-by-dual-energy-x-ray-absorptiometry-dexa-versus-serum-tartrate-resistant-acid-phosphatase-5b-trap-5b-in-children-with-classic-salt-losing-congenital-adrenal-hyperplasia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:28:57Z","timestamp":1746790137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/320765-bone-mineral-density-assessment-by-dual-energy-x-ray-absorptiometry-dexa-versus-serum-tartrate-resistant-acid-phosphatase-5b-trap-5b-in-children-with-classic-salt-losing-congenital-adrenal-hyperplasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.83778","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}